Journal article icon

Journal article

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

Abstract:

OBJECTIVE: While the lipido-sterolic extract of Serenoa repens (LSESr)-Permixon((R))-has been shown to have an equivalent efficacy to finasteride in patients with benign prostatic hyperplasia (BPH), to date, there has been no valid comparison of phytotherapy with alpha-blockers. The aim of this study was to assess the equivalent efficacy of Permixon and tamsulosin. METHODS: Eight hundred and eleven men with symptomatic BPH (I-PSS> or =10) were recruited in 11 European countries for a 12-m...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
European urology
Volume:
41
Issue:
5
Pages:
497-506
Publication date:
2002-05-05
DOI:
EISSN:
1873-7560
ISSN:
0302-2838
URN:
uuid:082b4a89-8768-4843-8af2-15bc8218a162
Source identifiers:
120662
Local pid:
pubs:120662

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP